Quantcast

Latest FDA Stories

2014-09-24 08:29:19

AARHUS, Denmark, September 24, 2014 /PRNewswire/ -- Customized embryo evaluation tools for IVF practices now available for clinical use in the USA World leading time-lapse technology provider within the field of IVF, Unisense FertiliTech A/S, has received FDA 510(k) clearance for its "Compare & Select" feature in the EmbryoViewer(TM) software - an accessory to the EmbryoScope(R) time-lapse incubator - which assists IVF professionals in selecting embryos for transfer...

2014-09-24 08:28:26

Newest Indication for Company's Disposable FOCUS Lens Array WESTFORD, Mass., Sept. 24, 2014 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that it has received FDA 510(k) clearance to market its flagship PicoSure Picosecond Laser Workstation for the treatment of wrinkles with the Company's new disposable energy delivery system, the FOCUS lens array. In the...

2014-09-23 23:11:13

FDA Advisors Also Recommended That Manufacturers of Testosterone Treatments Conduct Studies of Their Potential Heart Risks Chicago IL (PRWEB) September 23, 2014 The testosterone lawsuit attorneys at The Oliver Law Group P.C. were pleased to learn of the outcome of the U.S. Food & Drug Administration’s (FDA) recently-concluded advisory panel meeting, which the agency convened on September 17th to examine the risks and benefits of prescription low testosterone therapy. According to a...

2014-09-23 23:10:43

The Stork® OTC—the first-ever FDA-cleared home-use conception assistance device—launched today for over-the-counter sales in the U.S. For the one in six couples and others whose dream of having a baby is delayed by infertility or other issues, The Stork OTC delivers hope; it provides a safe, easy-to-use, cost-effective way to perform an established conception technique—cervical cap insemination—without drugs or invasive procedures, in the privacy of home. Pittsburgh, PA...

2014-09-23 16:27:41

Proceeds to drive manufacturing, sales and marketing programs for LabStyle's Dario(TM) in Europe and elsewhere, as well as ongoing FDA efforts CAESAREA, Israel, Sept. 23, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that it has closed a $4.2 million private placement offering consisting of shares of preferred stock and warrants. No placement agent was used for this financing. After estimated offering...

2014-09-23 08:30:35

Only FDA-approved and only Pregnancy Category A prescription treatment for Nausea and Vomiting of Pregnancy is now available in California and Nebraska through state-administered Medicaid Drug Rebate Programs ROSEMONT, Pa., Sept. 23, 2014 /PRNewswire/ -- Duchesnay USA today announced that Diclegis(® )(doxylamine succinate and pyridoxine hydrochloride) for the treatment of Nausea and Vomiting of Pregnancy (NVP)(1) is now available for coverage under both California's and Nebraska's...

2014-09-23 08:29:40

Fat Reduction Technology Generates Visible Results Within Two-Weeks Of Treatment FRANKLIN PARK, N.J., Sept. 23, 2014 /PRNewswire/ -- Arthur W. Perry, MD, FACS, a New Jersey based board-certified plastic surgeon, is the first physician in the Central New Jersey region to offer UltraShape(TM), a revolutionary treatment recently FDA cleared for Fat Cell Destruction. The UltraShape System, developed by medical device leader Syneron Candela, is the first and only non-invasive fat...

2014-09-22 23:13:00

On September 5, Mars Chocolate North America announced the recall of its Twix Unwrapped Bites 7 oz. Stand Up Pouch with specific code date due to allergy alert on undeclared peanuts and egg. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) September 22, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on...

2014-09-22 23:02:33

The Firm is investigating potential legal claims on behalf of women who allegedly experienced the spread of uterine sarcomas and other cancers due to uterine morcellation. New York, New York (PRWEB) September 22, 2014 As concerns about the potential risks associated with the use of power morcellators (http://www.gynecaremorcellatorlawsuit.com/) in gynecological surgeries mount, Bernstein Liebhard LLP notes a new report detailing the continued use of uterine morcellation by some doctors,...

2014-09-22 08:29:14

FDA Submission Reinforces Commitment to Addressing Significant Unmet Needs for Patients With Acute Lymphoblastic Leukemia, an Aggressive Cancer With Limited Treatment Options THOUSAND OAKS, Calif., Sept. 22, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval for its investigational bispecific T cell engager (BiTE(®)) antibody construct, blinatumomab. The BLA is...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.